Skip to main content

Table 2 Discounts by benefit categories and indication class

From: Benefit assessment in Germany: implications for price discounts

Additional benefit: considerable      
Indication class by ICD-10 n Mean Min Max SD
Certain infectious and parasitic diseases 11 23.80 10.07 42.54 13.96
Diseases of the circulatory system 1 19.35 19.35 19.35
Diseases of the eye and adnexa 1 15.43 15.43 15.43
Diseases of the musculoskeletal system and connective tissue 1 39.44 39.44 39.44
Endocrine, nutritional and metabolic diseases 1 5.05 5.05 5.05
Neoplasms 14 18.44 6.35 35.19 8.69
Overall 29 20.66 5.05 42.54 11.55
Size of target population (upper level) 29 18172 143 221000 40788
Additional benefit: minor
Indication class by ICD-10 n Mean Min Max SD
Certain infectious and parasitic diseases 12 18.48 0.00 42.54 13.78
Diseases of the circulatory system 6 29.97 4.65 58.73 20.21
Diseases of the digestive system 1 25.54 25.54 25.54
Diseases of the genitourinary system 2 19.80 19.80 19.80 0.00
Diseases of the nervous system 2 40.69 29.71 51.67 15.53
Diseases of the respiratory system 2 2.01 * 2.01 2.01 0.00
Endocrine, nutritional and metabolic diseases 10 15.02 1.00 25.31 7.36
Neoplasms 12 23.16 4.74 46.44 12.83
Other 1 24.50 24.50 24.50
Overall 48 20.93 0.00 58.73 20.16
Size of target population (upper level) 48 153723 6 2542810 425313
Additional benefit: non-quantifiable
Indication class by ICD-10 n Mean Min Max SD
Certain infectious and parasitic diseases 6 16.86 10.07 21.25 5.33
Diseases of the circulatory system 1 19.35 19.35 19.35
Diseases of the digestive system 1 14.87 14.87 14.87
Diseases of the respiratory system 1 10.96 10.96 10.96
Neoplasms 11 18.84 9.00 29.78 6.29
Other 2 13.64 13.64 13.64 0.00
Overall 22 17.31 * 9.00 29.778 55.32
Size of target population (upper level) 22 6081 25 34000 9994
No additional benefit
Indication class by ICD-10 n Mean Min Max SD
Certain infectious and parasitic diseases 22 24.45 3.16 42.54 11.01
Diseases of the digestive system 4 31.02 31.02 31.02 0.00
Diseases of the blood and blood-forming organs 2 24.50 23.15 25.85 1.91
Diseases of the circulatory system 6 22.49 4.65 49.52 14.69
Diseases of the eye and adnexa 6 20.13 3.06 78.02 29.04
Diseases of the nervous system 7 37.03 24.32 67.30 15.26
Diseases of the respiratory system 6 16.90 2.01 25.74 11.60
Diseases of the skin and subcutaneous tissue 1 42.75 42.75 42.75
Endocrine, nutritional and metabolic diseases 13 24.72 * 12.78 48.60 13.86
Mental and behavioral disorders 2 25.68 17.36 34.00 11.77
Neoplasms 19 20.43 0.00 53.71 13.92
Other 4 25.10 * 21.65 28.55 3.98
Overall 92 24.25 * 0.00 78.02 14.18
Size of target population (upper level) 92 170203 15 3253000 499215
  1. Abbreviations: Min minimum, Max maximum, SD standard deviation
  2. All discounts presented in %
  3. Assessment with “Major Benefit” = 13.64 % (TP upper level = 2333.33)
  4. Assessment with “Less Benefit” = 9.00 % (TP upper level = 1460)
  5. * p < 0.05 compared to mean discount of the other indications